Which hedge funds own XRAY? DENTSPLY SIRONA INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
9 of the hedge funds tracked by WhaleCreep disclosed a position in XRAY (DENTSPLY SIRONA INC) in their Q2 2026 13F filings, worth $104.2m in total. The largest holder by portfolio weight is Moore Capital Management at 0.1% of its book. 1 manager opened a new position this quarter: Bridgewater Associates. 2 exited: Ancora Advisors, Woodline Partners.
9tracked managers holding
1opened this quarter
2exited this quarter
Which hedge funds hold XRAY? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Moore Capital Management | Q2 2026 | 0.1% | $4.6m | 437,556 | -3% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $40.3m | 3,800,116 | -16% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $1.7m | 160,524 | 45% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $31.7m | 2,987,178 | 23% | added |
| Bridgewater Associates | Q2 2026 | 0.0% | $3.9m | 369,968 | – | new |
| Holocene Advisors | Q2 2026 | 0.0% | $4.3m | 408,657 | -43% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $9.1m | 857,482 | 47% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $8.1m | 762,317 | -45% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $355.0k | 33,458 | -98% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Ancora Advisors | 0.0% | $21.2k |
| Woodline Partners | 0.3% | $8.1m |
How has hedge fund ownership of XRAY changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 9 | $104.2m |
| Q1 2026 | 10 | $144.6m |
| Q4 2025 | 5 | $31.0m |
| Q3 2025 | 3 | $28.3m |
| Q2 2025 | 5 | $34.8m |
| Q1 2025 | 5 | $23.8m |
| Q4 2024 | 5 | $15.4m |
| Q3 2024 | 4 | $22.7m |
| Q2 2024 | 4 | $23.9m |
| Q1 2024 | 4 | $32.3m |
| Q4 2023 | 3 | $24.1m |
| Q3 2023 | 5 | $78.4m |
| Q2 2023 | 4 | $14.9m |
| Q1 2023 | 3 | $18.1m |
| Q4 2022 | 5 | $62.2m |
| Q3 2022 | 6 | $61.8m |
Counts every tracked manager that disclosed XRAY in that quarter's filing, including managers that have since stopped filing.